New survey highlights persistent cancer medication shortages across United States

The National Comprehensive Cancer Network (NCCN)—an alliance of leading cancer centers—has published updated data on the current impact of generic cancer medication shortages in the United States. The data come from survey responses from pharmacy directors and other clinical and administrative leaders at NCCN Member Institutions from late August. According to the results, 100% of responding cancer centers are experiencing a shortage of at least one anticancer agent, with more than 20% of centers currently experiencing shortages of five or more different medications.

≈